• #1221601
  • AbbVie US LLC #0074106501

SKYRIZI® Risankizumab-rzaa 150 mg / mL Injection Single-Dose Prefilled Cartridge 1.2 mL

SKYRIZI, INJ 180MG/1.2ML PF CARTRIDGE W/OBI D/S

Features
  • SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
  • 180 mg/1.2 mL (150 mg/mL) single-dose prefilled cartridge with on-body injector
  • More …
Container Type
Single-Dose Prefilled Cartridge Single-Dose Vial
Strength
60 mg / mL 150 mg / mL
Type
Intravenous Subcutaneous
Volume
1.2 mL 2.4 mL 10 mL
  Log In to Order
or

Product Specifications


Features
  • SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
  • 180 mg/1.2 mL (150 mg/mL) single-dose prefilled cartridge with on-body injector

Professionals Also Viewed